Analytics

SVP of advanced analytics Pravin Pant and associate VP of interoperability strategy Michael Gould, both at ZeOmega, discuss how providers should adopt FHIR standards to achieve TEFCA compliance and enable easier data sharing with payers.  

Aytan Dahukey, partner and private equity team leader, and healthcare team member at Sheppard Mullin, says that growth areas in private equity are opportunistic and discusses some challenges ahead.  

In part two of a two-part series, Dr. Bruce Darrow, CMIO and interim CDIO at Mount Sinai Health System, discusses how the health system utilizes AI for predictive care, reading diagnostic images, and streamlining administrative operations.  

Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.  

In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.  

McGill University Health Centre's Dr. Alan Forster discusses the Quadruple Aim and using data to understand opportunities for development and improvement.  

Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA, says AI can support, not replace, clinicians in improving care delivery, and discusses some best practices for its safe and ethical use. The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.  

David Wolf, MedeAnalytics AVP, and Lynn Carroll, HSBlox COO, highlight value-based care models' crucial components, including contract modeling and performance measurement, and discuss change management for switching to these models.  

Dr. John Showalter, Linus' chief product officer, discusses the company's cognitive impairment testing and care-delivery offerings for dementia diagnosis and treatment and its acquisition of speech analytics platform Aural Analytics.  

Ziv Ofek, cofounder and CEO of MDClone, discusses how GenAI tools may soon make it easier for clinicians to analyze synthetic data themselves if guardrails are in place to ensure that the AI's conclusions are correct.